- Rank in Search Criteria: 5241
World Rank (Jan-05-2024): 17,706
Market Cap (Jan-05-2024): 0.21 Billion USD
World Rank (Jul-30-2023): 18157
Market Cap (Jul-30-2023): 0.20 Billion USD
World Rank (Jan-2022): 17,589
Market Cap (Jan-2022): 0.26 Billion USDHeadquarters Country: USA Annual Revenue in USD: 5 Million USD
Annual Net Income in USD: 5 Million USD
Annual Results for Period ending: Oct-2020 ending year
- Rank in Search Criteria: 5242
World Rank (Jan-05-2024): 17,712
Market Cap (Jan-05-2024): 0.21 Billion USD
World Rank (Jul-30-2023): 17428
Market Cap (Jul-30-2023): 0.23 Billion USD
- Rank in Search Criteria: 5243
World Rank (Jan-05-2024): 17,712
World Rank (Jul-30-2023): 17712
Market Cap (Jul-30-2023): 0.21 Billion USD
Headquarters Country: USA
- Rank in Search Criteria: 5244
World Rank (Jan-05-2024): 17,714
Market Cap (Jan-05-2024): 0.21 Billion USD
World Rank (Jul-30-2023): 17807
Market Cap (Jul-30-2023): 0.21 Billion USD
World Rank (Jan-2022): 13,662
Market Cap (Jan-2022): 0.48 Billion USDHeadquarters Country: USA Annual Revenue in USD: 0 Million USD
Annual Net Income in USD: -111 Million USD
Annual Results for Period ending: Dec-2021 ending yearEmployee Count: 115
Employee Count as of Date: As on July 2022
Company Profile: Prelude Therapeutics is a Clinical Stage Biopharmaceutical company. The company estimated annual revenue is currently 8.5 million USD per year and 55 employees as on 2019. The headquarters is in USA.
- Rank in Search Criteria: 5245
World Rank (Jan-05-2024): 17,715
Market Cap (Jan-05-2024): 0.21 Billion USD
World Rank (Jul-30-2023): 15334
Market Cap (Jul-30-2023): 0.33 Billion USD
World Rank (Jan-2022): 15,545
Market Cap (Jan-2022): 0.36 Billion USDHeadquarters Country: USA Annual Revenue in USD: 227 Million USD
Annual Net Income in USD: -115 Million USD
Annual Results for Period ending: Dec-2020 ending year
- Rank in Search Criteria: 5246
World Rank (Jan-05-2024): 17,718
Market Cap (Jan-05-2024): 0.21 Billion USD
World Rank (Jul-30-2023): 14968
Market Cap (Jul-30-2023): 0.35 Billion USD
World Rank (Jan-2022): 17,392
Market Cap (Jan-2022): 0.27 Billion USDHeadquarters Country: USA Annual Revenue in USD: 14 Million USD
Annual Net Income in USD: 5 Million USD
Annual Results for Period ending: Dec-2020 ending year
- Rank in Search Criteria: 5247
World Rank (Jan-05-2024): 17,719
World Rank (Jul-30-2023): 17719
Market Cap (Jul-30-2023): 0.21 Billion USD
World Rank (Jan-2022): 13,665
Market Cap (Jan-2022): 0.48 Billion USDHeadquarters Country: USA Annual Revenue in USD: 0 Million USD
Annual Net Income in USD: -154 Million USD
Annual Results for Period ending: May-2021 ending yearEmployee Count: 24
Employee Count as of Date: As on 2021
Company Profile: CytoDyn is a Biotechnology company focused on developing innovative treatments for multiple therapeutic indications. The company has 19 full time employees as on 2020. The headquarters is in USA.
- Rank in Search Criteria: 5248
World Rank (Jan-05-2024): 17,719
Market Cap (Jan-05-2024): 0.21 Billion USD
World Rank (Jul-30-2023): 18474
Market Cap (Jul-30-2023): 0.19 Billion USD
World Rank (Jan-2022): 18,528
Market Cap (Jan-2022): 0.22 Billion USDHeadquarters Country: USA Annual Revenue in USD: 9 Million USD
Annual Net Income in USD: 7 Million USD
Annual Results for Period ending: Dec-2020 ending year
- Rank in Search Criteria: 5249
World Rank (Jan-05-2024): 17,720
Market Cap (Jan-05-2024): 0.21 Billion USD
World Rank (Jul-30-2023): 19589
Market Cap (Jul-30-2023): 0.15 Billion USD
World Rank (Jan-2022): 21,116
Market Cap (Jan-2022): 0.14 Billion USDHeadquarters Country: USA Annual Revenue in USD: 97 Million USD
Annual Net Income in USD: 2 Million USD
Annual Results for Period ending: Dec-2020 ending year
- Rank in Search Criteria: 5250
World Rank (Jan-05-2024): 17,726
World Rank (Jul-30-2023): 17726
World Rank (Jan-2022): 18,928
Market Cap (Jan-2022): 0.20 Billion USD